Pyrrolo[1,2-a]quinazolines have raised some interest as bioactive scaffolds but their synthetic strategies based mainly on the anthranilic acid route have been rather limited. The last two decades have brought new approaches to the synthesis of pyrrolo[1,2-a]quinazoline framework and thus their potential could be valued in the obtaining of new lead compounds from the important class of quinazolines. Herein we present the synthetic strategies towards compounds containing the pyrrolo[1,2-a]quinazoline scaffold and their biological properties.
atom. [5] [6] [7] The N-ylide approach to pyrrolo [1,2-a] quinazolines is versatile in providing series of compounds by simple procedures. In the literature are known three main routes to these compounds via quinazolinium N-ylides, starting either from dichloroquinazolinium ylide (2) or the unsubstituted (3) or a monosubstituted quinazolinium N-ylide (4) . The pyrrolo[1,2-a]quinazoline 5 (Scheme 1) was obtained by Khlebnikov et al. 8 in mixture with other two isomers from the corresponding dichloroquinazolinium N-ylide 2. Their synthetic strategy in obtaining pyrrolo-fused compounds was the 1,3-dipolar cycloaddition of the quinazolinium dichloromethanides generated in situ by the reaction of the quinazoline with dichlorocarbenes, in presence of different dipolarophiles such as dimethyl maleate. The result of the reaction was a mixture of isomeric pyrroloquinazolines, as the dichlorocarbene could also react at the N3 of the quinazoline generating the corresponding N-ylide. In some cases the fully aromatic compounds were obtained by using an oxidizing agent. 
Scheme 1
Azouz et al. 9 obtained the tetrahydropyrrolo[1,2-a]quinazolines 6 and 7 starting with carbanion-unsubstituted quinazolinium N1-ylides using activated olefinic dipolarophiles (Scheme 2). The yields however were not high. When they employed dimethyl acetylenedicarboxylate (DMAD) as dipolarophile, an in situ ring-opening of the pyrroloquinazoline was observed with the formation of the corresponding N-arylpyrrole, but no further studies were performed in this direction. 
Scheme 2
Recently, during the investigation on the cycloaddition reaction between monosubstituted quinazolinium ylides and symmetrical or unsymmetrical acetylenic dipolarophiles with the aim of obtaining pyrrolo[1,2-a]quinazolines, 10 the formation of substituted N-arylpyrroles 10,11 was observed. The dihydropyrrolo[1,2-a]quinazoline 8 was obtained however by using triethylamine as base in ethanol as solvent, and was characterized by NMR (Scheme 3). The pyrrolo[1,2-a]-quinazoline derivatives 9 were observed in mixtures with the pyrroles only in the case when dimethyl acetylenedicarboxylate was used as dipolarophile (R = E = COOMe) and were isolated in two cases with moderate yields. [13] [14] [15] [16] [17] [18] [19] [20] By intramolecular cyclisation of the 1,2-dihydroquinazolinepropionitrile 3-oxides in alkaline media (Scheme 4) the corresponding 1-iminotetrahydropyrrolo[1,2-a]quinazoline-4-oxides 10 were obtained. 
Scheme 4
Another approach to the pyrrolo[1,2-a]quinazoline skeleton is by the interlinking of substituents in the positions 1 and 2 of a disubstituted quinazolin-4-one in a Dieckmann type reaction such as is depicted in Scheme 5. The four pyrrolo [ 
Scheme 6
Starting from 2-phenacylidene-1,2-dihydro-4H-3,1-benzoxazin-4-one, in a two-step synthesis the pyrrolo[1,2-a]quinazolones 17 were obtained in yields of over 90% (Scheme 7). 
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Scheme 7
More recently the synthesis of pyrrolo[1,2-a]quinazolinones 19 was achieved starting from 3-amino-2-methylquinazolinone (18) by cyclisation with cinnamonitrile derivatives in ethanol at reflux, in the presence of a catalytic amount of piperidine (Scheme 8). 20 The compound 18 was obtained from anthranilic acid. 
Syntheses starting from N-arylpyrroles
The interest in syntheses of heterocycles starting from substituted N-arylpyrroles has been also directed on the obtaining of pyrrolo[1,2-a]quinazolines. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Noticing the availability of the 2-aminobenzophenones in the synthesis of certain heterocycles, Garcia et al. 24 extended these studies to pyrrole and pyrrolo-fused derivatives. Thus, starting from 
Scheme 9
Using a similar strategy, Ishikawa et al. succeeded in cyclizing the oximes 23 over a catalyst of NaOH and Raney nickel as shown in Scheme 10, to obtain 24. 
Scheme 10
There is also a report that on flash vacuum pyrolysis (FVP) of the pyrrole oxime 25 the parent pyrrolo[1,2-a]quinazoline (26) is obtained (Scheme 11) as the major product in a mixture with the pyrrole 27. 27 The author also presents a study on the reaction mechanism leading to the pyrrolo[1,2-a]quinazoline and extends his work on the reactivity of this parent heterocycle. 
Scheme 11
Mohrle et al. 28 
34
Other reactions involving pyrrole intermediates were reported by Schaefer starting from Naryl-4-amino-5-cyano-2,3-dihydro-1H-pyrrol-2-ones. 34 
Synthesis by the tert-amino effect
By the cyclisation of the ortho substituted anilines of type 35, also known as tert-amino effect, the compounds 36 were obtained in medium yields. 35 Recently, using the tert-amino effect Akyiama et al. 36 have isolated the pyrrolo[1,2-a]quinazoline 36 having as substituents R = H, R 1 = H and Ar = 
Syntheses by double cyclisation reactions
Various substituted quinazolines were obtained in two step reactions involving in the first step the formation of the bicyclic quinazoline or a N-arylpyrrole system followed in the second step by intramolecular cyclisation to the desired tricyclic pyrrolo [ 
Scheme 25
By condensating 3-(4-chlorobenzoyl)propionic acid 58 with the amine 59 the hydrogenated pyrrolo[1,2-a]quinazoline 60 was obtained (Scheme 26). 94, 95 Studies were made in order to obtain specific stereoisomers of 60 starting from specific stereoisomers of the amine 59. Some studies regarding the fragmentation of such compounds by mass spectrometry should be mentioned. 
Scheme 26
In a one step reaction starting from substituted 2-aminobenzophenones and 2-haloalkylidene propanedinitriles Dave and Shah obtained (Scheme 27) the pyrrolo[1,2-a]quinazolines 61. 
Scheme 28
The compounds 63 were prepared in 70-100 gram scale by reaction of 2-amino-Nalkyl(aryl)benzamides with 2-oxoglutaric acid. 
Scheme 29
By the same strategy of metal reduction-condensative cyclization strategy Bunce and Nammalwar obtained similar compounds using Fe as metal catalyst and starting from the unsubstituted 2-nitrobenzamide in reaction with linear keto bearing compounds. 102 Recently a synthesis 103 
Biological Properties of the Pyrrolo[1,2-a]quinazolines
The biological properties of the pyrrolo[1,2-a]quinazoline system have not been much investigated, perhaps because of the scarcity of preparative routes to such compounds. However, there are some reports and patents claiming potentially bioactive pyrrolo[1,2-a]quinazolines and these will be presented briefly in this chapter.
Antibiotic activity
Compounds 54 (Scheme 24) are reported as antibiotics, 91 but the author did not mention the specific antibiotic activity.
Analgesic, anti-inflammatory and antipyretic activity
Compounds of structure 68 are known to possess analgesic, anti-inflammatory and antipyretic properties. The patent contains also the pharmaceutical formulation of the active ingredients as capsules or tablets. The pyrrolo[1,2-a]quinazolines 71 are claimed to possess hypotensive activity by regulating the blood pressure. 40 The authors propose also pharmaceutical formulations for the compounds.
Compounds similar to 71 substituted at N4 or possessing a carbonyl at C-1 are also claimed to possess antihypertensive properties. 48 The inventors also present possible formulations as tablets for orally administration. The mechanism of action is not clearly defined; thus the compounds could have CNS depressant action also. 
Bioactive compounds acting on the respiratory system
Compounds with general formula 72 were tested on guinea pigs and found to possess bronchodilatator properties. 106 The patent includes a pharmacological formulation and possible administration methods. These compounds are claimed to be suited to the treatment of bronchial asthma. 
Central nervous system activity
Compounds with general formula 73 were tested as CNS depressants. The tests on mice showed decreased motor-activity, respiration and sedative-ataxic effects. 47 The compounds 71 with similar structure were also claimed to possess CNS depressant activity. 40 The same authors present some pyrrolo[1,2-a]quinazolines with potential tranquilizant activity, 90 but the patent lacks details on how this activity was tested and measured. Compounds of formula 10 are reported only as intermediates in obtaining open cycle compounds as CNS depressants. 13 The authors don't seem to provide biological data on the compounds 10 included in the patent. The pyrrolo[1,2-a]quinazoline 74 was tested together with other quinazoline structure related compounds as sedatives, having potentiating barbiturate properties and are thus claimed to be useful as adjuvants in the treatment of convulsions, insomnia or mental disorders. 53 This work is a continuation of a previous report by the same authors. 46 The patent could refer to other analogs of the general formula 75. Pyrrolo[1,2-a]quinazolines with anticonvulsant properties are also reported in a German patent. Compounds 54 (Scheme 23) are also claimed to possess CNS depressant activity, mydriasis being one of the effects. 
